Tacrobell tab_Phase1_PK

Clinical trial NCT02336854 · COMPLETED

Trial details

NCT number: NCT02336854
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immunosuppressant(Organ Transplantation, RA)

Start date: 2015-01-12
Primary completion: 2015-02-02
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.